MESO
$5.53
Revenue | $2.14Mn |
Net Profits | $-21.92Mn |
Net Profit Margins | -1024.73% |
Mesoblast’s revenue fell -3.82% since last year same period to $2.14Mn in the Q2 2023. On a quarterly growth basis, Mesoblast has generated 10.31% jump in its revenue since last 3-months.
Mesoblast’s net profit fell -2.16% since last year same period to $-21.92Mn in the Q2 2023. On a quarterly growth basis, Mesoblast has generated -17.84% fall in its net profits since last 3-months.
Mesoblast’s net profit margin fell -6.22% since last year same period to -1024.73% in the Q2 2023. On a quarterly growth basis, Mesoblast has generated -6.83% fall in its net profit margins since last 3-months.
EPS Estimate Current Quarter | -0.11 |
EPS Estimate Current Year | -0.11 |
Mesoblast’s earning per share (EPS) estimates for the current quarter stand at -0.11 - a 71.55% jump from last quarter’s estimates.
Mesoblast’s earning per share (EPS) estimates for the current year stand at -0.11.
Earning Per Share (EPS) | 0 |
Mesoblast’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q1 2024. This indicates that the Mesoblast has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2024-05-30 | -0.11 | 0 | 100% |